Colorectal cancer (CRC), the third leading cause of death among cancer patients, is characterized by the uncontrolled proliferation of cells in the colorectal region. The prevalence of CRC has increased and as of 2020, 10% of global cancer incidence and 9.4% of cancer-related deaths were accounted by CRC. 1,2 Early screening is essential for an accurate diagnosis and for planning an effective treatment strategy for the patient.
The American Cancer Society of Colorectal Cancer (ACC) has proposed qualified and strong recommendations for the diagnosis of CRC. Even though conventional screening tests help to diagnose CRC, advanced testing using biomarkers such as KRAS, BRAF, and MSI help in the definitive diagnosis of the condition. 3-5 This video highlights the prevalence of CRC among people, various diagnostic techniques for the definitive diagnosis of CRC, and also introduces the test…
